Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

August’s top stories: Pfizer-Merck lung cancer trial, Amgen’s Phase III for ASPIRE

Pfizer and Merck team up on Phase Ib combination trial to treat lung cancer and Amgen's Phase III ASPIRE trial of myeloma treatment Kyprolis meets primary endpoint while Mesoblast and NIH partner on 120-patient trial to treat end-stage heart failure. Drugdevelopment-technology.com wraps up key headlines from August.

Go Top